Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects

Beneficial Microbes

Volumn 7, Issue 4, 2016, Pages 511-517

  Hippe, B ^a   Remely, M ^a   Aumueller, E ^a   Pointner, A ^a   Magnet, U ^a   Haslberger, A G ^a  

^a Institute of Nutritional Sciences   (Austria)

Author keywords

Butyryl CoA:acetate CoA transferase (BUT) gene; Fragment length polymorphism; High resolution melt curve analysis; Low grade inflammation

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; BUTYRYL COENZYME A ACETATE; BUTYRYL COENZYME A TRANSFERASE; RNA 16S; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIABETIC PATIENT; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FEEDING BEHAVIOR; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENETIC VARIABILITY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OBESITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BACTERIAL GENE; CLASSIFICATION; COMPLICATION; DIABETES MELLITUS, TYPE 2; FECES; GENETICS; METABOLISM; MICROBIOLOGY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; BUTYRATES; DIABETES MELLITUS, TYPE 2; FAECALIBACTERIUM PRAUSNITZII; FECES; FEMALE; GENES, BACTERIAL; HUMANS; MALE; OBESITY; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84988876296     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2015.0075     Document Type: Article

References (44)

1. Anonymous, 2010. Executive summary: standards of medical care in diabetes-2010. Diabetes Care 33 Suppl 1: S4-S10.
2. Avci, F.Y., Li, X., Tsuji, M. and Kasper, D.L., 2013. Carbohydrates and T cells: a sweet twosome. Seminars in Immunology 25: 146-151.
3. Balamurugan, R., George, G., Kabeerdoss, J., Hepsiba, J., Chandragunasekaran, A.M. and Ramakrishna, B.S., 2010. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. British Journal of Nutrition 103: 335-338.
4. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., Muir, A.I., Wigglesworth, M.J., Kinghorn, I., Fraser, N.J., Pike, N.B., Strum, J.C., Steplewski, K.M., Murdock, P.R., Holder, J.C., Marshall, F.H., Szekeres, P.G., Wilson, S., Ignar, D.M., Foord, S.M., Wise, A. and Dowell, S.J., 2003. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. Journal of Biological Chemistry 278: 11312-11319.
5. Cani, P.D. and Delzenne, N.M., 2011. Benefits of bariatric surgery: an issue of microbial-host metabolism interactions? Gut 60: 1166-1167.
6. Duncan, S.H., Belenguer, A., Holtrop, G., Johnstone, A.M., Flint, H.J. and Lobley, G.E., 2007. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Applied and Environmental Microbiology 73: 1073-1078.
7. Duncan, S.H., Hold, G.L., Harmsen, H.J., Stewart, C.S. and Flint, H.J., 2002. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology 52: 2141-2146.
8. Feng, J., Tang, H., Li, M., Pang, X., Wang, L., Zhang, M., Zhao, Y., Zhang, X. and Shen, J., 2014. The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults. Archives in Microbiology 196: 73-77.
9. Finley, B.L., Monnot, A.D., Paustenbach, D.J. and Gaffney, S.H., 2012. Derivation of a chronic oral reference dose for cobalt. Regulatory Toxicology and Pharmacology 64: 491-503.
10. Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L., Mariat, D., Corthier, G., Dore, J., Henegar, C., Rizkalla, S. and Clement, K., 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057.
11. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K. and Ohno, H., 2013. Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446-450.
12. Gerritsen, J., Smidt, H., Rijkers, G.T. and De Vos, W.M., 2011. Intestinal microbiota in human health and disease: the impact of probiotics. Genes and Nutrition 6: 209-240.
13. Gunzel, D. and Yu, A.S., 2013. Claudins and the modulation of tight junction permeability. Physiological Reviews 93: 525-569.
14. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J. and Brummer, R.J., 2008. Review article: the role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics 27: 104-119.
15. Heinken, A., Khan, M.T., Paglia, G., Rodionov, D.A., Harmsen, H.J. and Thiele, I., 2014. Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe. Journal of Bacteriology 196: 3289-3302.
16. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C.J., Fagerberg, B., Nielsen, J. and Backhed, F., 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498: 99-103.
17. Knych, H.K., Arthur, R.M., Mitchell, M.M., Holser, I., Poppenga, R., Smith, L.L., Helm, M.N., Sams, R.A. and Gaskill, C.L., 2015. Pharmacokinetics and selected pharmacodynamics of cobalt following a single intravenous administration to horses. Drug Testing and Analysis 7: 619-625.
18. Kroke, A., Klipstein-Grobusch, K., Voss, S., Moseneder, J., Thielecke, F., Noack, R. and Boeing, H., 1999. Validation of a self-administered foodfrequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. American Journal of Clinical Nutrition 70: 439-447.
19. Layden, B.T., Angueira, A.R., Brodsky, M., Durai, V. and Lowe Jr., W.L., 2013. Short chain fatty acids and their receptors: new metabolic targets. Translational Research 161: 131-140.
20. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jorgensen, T., Brandslund, I., Nielsen, H.B., Juncker, A.S., Bertalan, M., Levenez, F., Pons, N., Rasmussen, S., Sunagawa, S., Tap, J., Tims, S., Zoetendal, E.G., Brunak, S., Clement, K., Dore, J., Kleerebezem, M., Kristiansen, K., Renault, P., Sicheritz-Ponten, T., de Vos, W.M., Zucker, J.D., Raes, J., Hansen, T., Bork, P., Wang, J., Ehrlich, S.D., Pedersen, O., Guedon, E., Delorme, C., Layec, S., Khaci, G., van de Guchte, M., Vandemeulebrouck, G., Jamet, A., Dervyn, R., Sanchez, N., Maguin, E., Haimet, F., Winogradski, Y., Cultrone, A., Leclerc, M., Juste, C., Blottiere, H., Pelletier, E., LePaslier, D., Artiguenave, F., Bruls, T., Weissenbach, J., Turner, K., Parkhill, J., Antolin, M., Manichanh, C., Casellas, F., Boruel, N., Varela, E., Torrejon, A., Guarner, F., Denariaz, G., Derrien, M., Van Hylckama Vlieg, J.E., Veiga, P., Oozeer, R., Knol, J., Rescigno, M., Brechot, C., M'Rini, C., Merieux, A. and Yamada, T., 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546.
21. Lin, H.V., Frassetto, A., Kowalik, E.J., Jr., Nawrocki, A.R., Lu, M.M., Kosinski, J.R., Hubert, J.A., Szeto, D., Yao, X., Forrest, G. and Marsh, D.J., 2012. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PloS One 7: e35240.
22. Lopez-Siles, M., Khan, T.M., Duncan, S.H., Harmsen, H.J.M., Garcia-Gil, L.J. and Flint, H.J., 2012. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Applied and Environmental Microbiology 78: 420-428.
23. Louis, P., Duncan, S.H., McCrae, S.I., Millar, J., Jackson, M.S. and Flint, H.J., 2004. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. Journal of Bacteriology 186: 2099-2106.
24. Louis, P. and Flint, H.J., 2007. Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Applied and Environmental Microbiology 73: 2009-2012.
25. Louis, P. and Flint, H.J., 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters 294: 1-8.
26. Louis, P., Young, P., Holtrop, G. and Flint, H.J., 2010. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environmental Microbiology 12: 304-314.
27. Million, M., Lagier, J.C., Yahav, D. and Paul, M., 2013. Gut bacterial microbiota and obesity. Clinical Microbiology and Infection 19: 305-313.
28. Miquel, S., Martin, R., Rossi, O., Bermudez-Humaran, L.G., Chatel, J.M., Sokol, H., Thomas, M., Wells, J.M. and Langella, P., 2013. Faecalibacterium prausnitzii and human intestinal health. Current Opinion in Microbiology 16: 255-261.
29. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C., Verdenelli, M.C., Clavel, T., Koebnick, C., Zunft, H.-J.F., Doré, J. and Blaut, M., 2006. Differences in fecal microbiota in different european study populations in relation to age, gender, and country: a cross-sectional study. Applied and Environmental Microbiology 72: 1027-1033.
30. Pegorier, J.P., Le May, C. and Girard, J., 2004. Control of gene expression by fatty acids. Journal of Nutrition 134: 2444S-2449S.
31. Petersen, K.F., Dufour, S., Befroy, D., Garcia, R. and Shulman, G.I., 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. New England Journal of Medicine 350: 664-671.
32. Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., Pointner, A., Brath, H. and Haslberger, A.G., 2013. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537: 85-92.
33. Rinttila, T., Kassinen, A., Malinen, E., Krogius, L. and Palva, A., 2004. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. Journal of Applied Microbiology 97: 1166-1177.
34. Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., Hammer, R.E., Williams, S.C., Crowley, J., Yanagisawa, M. and Gordon, J.I., 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the USA 105: 16767-16772.
35. Schwiertz, A., Taras, D., Schafer, K., Beijer, S., Bos, N.A., Donus, C. and Hardt, P.D., 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
36. Scott, K.P., Gratz, S.W., Sheridan, P.O., Flint, H.J. and Duncan, S.H., 2013. The influence of diet on the gut microbiota. Pharmacological Research 69: 52-60.
37. Tilg, H. and Moschen, A.R., 2014. Microbiota and diabetes: an evolving relationship. Gut 63: 1513-1521.
38. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
39. Vital, M., Penton, C.R., Wang, Q., Young, V.B., Antonopoulos, D.A., Sogin, M.L., Morrison, H.G., Raffals, L., Chang, E.B., Huffnagle, G.B., Schmidt, T.M., Cole, J.R. and Tiedje, J.M., 2013. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome 1: 8.
40. Walker, A.W., Ince, J., Duncan, S.H., Webster, L.M., Holtrop, G., Ze, X., Brown, D., Stares, M.D., Scott, P., Bergerat, A., Louis, P., McIntosh, F., Johnstone, A.M., Lobley, G.E., Parkhill, J. and Flint, H.J., 2012. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME Journal 5: 220-230.
41. Wang, H.-B., Wang, P.-Y., Wang, X., Wan, Y.-L. and Liu, Y.-C., 2012. Butyrate enhances intestinal epithelial barrier function via upregulation of tight junction protein claudin-1 transcription. Digestive Diseases and Sciences 57: 3126-3135.
42. Wichmann, A., Allahyar, A., Greiner, T.U., Plovier, H., Lunden, G.O., Larsson, T., Drucker, D.J., Delzenne, N.M., Cani, P.D. and Backhed, F., 2013. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host and Microbe 14: 582-590.
43. Wrzosek, L., Miquel, S., Noordine, M.L., Bouet, S., Joncquel Chevalier-Curt, M., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., Robbe-Masselot, C., Langella, P. and Thomas, M., 2013. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biology 11: 61.
44. Xu, J., Lian, F., Zhao, L., Zhao, Y., Chen, X., Zhang, X., Guo, Y., Zhang, C., Zhou, Q., Xue, Z., Pang, X., Zhao, L. and Tong, X., 2015. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME Journal 9: 552-562.